BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 16483032)

  • 1. A boost to hepatitis B vaccine: no need for boosters.
    Aggarwal R
    Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
    [No Abstract]   [Full Text] [Related]  

  • 2. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to hepatitis B vaccination in high risk population.
    Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
    J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers.
    Chirico G; Belloni C; Gasparoni A; Cerbo RM; Rondini G; Klersy C; Orsolini P; Filice G
    Pediatrics; 1993 Nov; 92(5):717-9. PubMed ID: 8414862
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological response to hepatitis B vaccine in polytransfused thalassemic patients.
    Alavian SM; Tabatabaei SV
    Pediatr Hematol Oncol; 2010 May; 27(4):324-5; author reply 326-7. PubMed ID: 20426525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the immunizing potency of hematogenic hepatitis B vaccine].
    Kang P
    Zhonghua Hu Li Za Zhi; 1993 Nov; 28(11):643-5. PubMed ID: 8124773
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination: time for a booster?
    Shopper T
    LDA J; 1992; 51(3):5-6. PubMed ID: 9518764
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
    Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
    Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of detecting HBV DNA with nested-PCR in the sera from patients with anti-HBs positive].
    Huang LH; Jiang YM; Huang ZH; Wu HY; Yang XJ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):631-2. PubMed ID: 14572352
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical efficacy and immunologic responses of hepatitis B vaccination in very-low-birth-weight infants.
    Yang YJ; Lin CH; Tai YT; Huang SC; Lin YJ
    Pediatr Infect Dis J; 2008 Aug; 27(8):768. PubMed ID: 18574432
    [No Abstract]   [Full Text] [Related]  

  • 18. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report.
    But DY; Lai CL; Lim WL; Fung J; Wong DK; Yuen MF
    Vaccine; 2008 Dec; 26(51):6587-91. PubMed ID: 18835318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B immunisation leads to the decline of hepatitis B virus prevalence in Gansu province, China.
    Liu C; Li H; Gao L; Li F; Liang X; Yang K
    Aust N Z J Public Health; 2011 Feb; 35(1):91-2. PubMed ID: 21299712
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity of hepatitis B vaccine incorporated into the expanded program of immunization schedule.
    Gomber S; Sharma R; Ramachandran VG; Talwar V; Singh B
    Indian Pediatr; 2000 Apr; 37(4):411-3. PubMed ID: 10781235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.